Radiant™ Aura Receives U.S. Food and Drug Administration (FDA) 510(k) Clearance
Expands office-based treatment options for millions of non-melanoma skin cancer (NMSC) patients
Xstrahl, a global leader in the delivery of superficial radiation therapy devices and preclinical radiation research systems, announced its Radiant™ Aura treatment solution has received U.S. Food and Drug Administration (FDA) 510(k) clearance. With advanced features for expanded clinical use, simplified patient positioning, and additional patient comfort, Radiant Aura brings radiation therapy to NMSC patients in any dermatology office.
Radiant
Treating My Skin Cancer with Superficial Radiation Therapy was the Perfect Alternative to Surgery
Myrna has a history of multiple skin cancers that were treated with Mohs micrographic surgery. During the last year, Myrna was diagnosed twice with basal cell carcinomas (BCC). Her dermatologist, Dr. John Binhlam of Advanced Skin & Laser Center, in Brentwood, Tennessee recommended superficial radiation therapy (SRT) as an alternative to Mohs surgery based on several factors unique to her. Myrna had SRT treatment delivered with the RADiant system, right in Dr. Binhlam’s office.
Superficial Radiation Therapy was a Simple Choice for My Skin Cancer
Marcia is 74 years old and a great-grandmother from Bell Buckle, Tennessee. Last year, she noticed bleeding from a tiny spot on the tip of her nose. At her next appointment, she had her dermatologist, Dr. John Binhlam, take a closer look. He did a biopsy on the spot, and she was diagnosed with an invasive squamous cell carcinoma (SCC) of the nasal tip. After a discussion of Mohs micrographic surgery versus nonsurgical superficial radiation therapy (SRT), Marcia chose to have the latter treatment done using the RADiant system at his office, Advanced Skin & Laser Center in Brentwood, Tennessee.
Expanding Patient-Centric Treatment Options for NMSC with Radiation Therapy
Dermatologists are frequently leading the way in the diagnosis and management of non-melanoma skin cancer (NMSC). While Mohs surgery is the standard of care in the treatment of NMSC, the final decision on treatment for the patient should be based on their health, age,...
Easy Non-Surgical Superficial Radiation Therapy was Ideal for My Skin Cancer
Mike had a quarter-sized spot on his leg that was not healing. A patient of Dr. John Binhlam’s dermatology practice for more than 20 years, he decided to seek treatment to heal his leg. A diagnosis of squamous cell carcinoma led him to non-surgical superficial radiation therapy (SRT) treatment from Dr. Binhlam using the RADiant system at Advanced Skin & Laser Center in Brentwood, TN.
Medical System Comparison
Each of our systems have unique energy ranges, applicators, and treatment capabilities. Learn which of our radiotherapy systems is right for you and your patients by watching the video below. Our Chief Science Officer, Amanda Tulk, outlines the key differences of each...
RADiant Overview by Xstrahl’s CEO, Adrian Treverton
Learn about RADiant from Xstrahl's CEO, Adrian Treverton. RADiant is a portable and easy-to-use system that can treat a range of skin conditions, including skin cancer. https://vimeo.com/711329383
Spotlight on Precision Dermatology: Texas Physicians Work Together to Expand NMSC Treatment Options
One common question dermatologists often ask about incorporating radiation therapy into their practice is “How much involvement do I need from a radiation oncologist?” Regulations concerning physician supervision, reimbursement, and radiation shielding can vary quite...
Office-Based Surface Radiotherapy for the Dermatology Clinic: A Two-Case Study
While surgery is still the treatment of choice for cutaneous malignancy, newer technologies such as surface radiotherapy can provide an alternative for patients who with non-melanoma skin cancers. Learn more about radiotherapy in the clinic setting through the case...